Practice Management News

From 2006 to 2018, the proportion of primary care visits addressing mental health concerns jumped by almost 50%, highlighting the need for resources that support behavioral health integration into primary care, according to researchers.

Long-term joint exposure to multiple air pollutants at low concentrations may be associated with an increased risk of depression and anxiety, according to a study published in JAMA Psychiatry.

Yale School of Medicine has established a research center to examine the association of cannabis and cannabinoids with neurodevelopment and mental health, the school announced in a press release.

In the United States, there were more than 600 excess deaths among physicians from March 2020 to December 2021, according to a research letter published in JAMA Internal Medicine.

The American Psychiatric Association plans to align treatment of eating disorders with a focus on risk-benefit analysis of physical and psychosocial factors, according to new guidelines published in the American Journal of Psychiatry.

Medication administration errors led to negative feelings of guilt, fear and self-blame, according to a study published in BMC Health Services Research.

With a rising number of clinical studies demonstrating the potential benefits of psychedelic treatments for a wide range of behavioral health conditions, insurance plan provider Enthea aims to expand employer funding for these services.

A California-based biopharmaceutical company has announced the completion of its acquisition of Pherin Pharmaceuticals Inc., a drug development firm that specializes in neuropsychiatric and neuroendocrine issues.

There has been a lot of attention about a proposed rule from the Federal Trade Commission that would prohibit many noncompetes. However, much of the discussion has been misleading, if not entirely wrong.

U.S. physicians experienced more burnout and work-related stress in 2022 than in 2021, according to a recent survey.